PlaqueTec

PlaqueTec has raised £3.7m in an oversubscribed financing round funded by its existing investor base to develop its cardiovascular disease database. Summary of transaction details: Value: £3.7m Sector: Healthcare & Biotech Advisor: Not disclosed Key Entities: PlaqueTec, existing investor base Location: Cambridge, UK Note: The funding will support the continued build-out of PlaqueTec's proprietary cardiovascular data lake, BioCarta, which aims to provide a novel site-of-disease strategy to inform how inflammatory risk in CVD is targeted.

PlaqueTec, a medtech company, has announced a £3.7 million investment from its existing investor base, which will be used to support the build-out of its proprietary cardiovascular data lake. Summary of transaction details: Value: £3.7 million Sector: Healthcare & Biotech Advisor: Not disclosed Key Entities: PlaqueTec, existing investor base Location: Cambridge, UK Note: This investment demonstrates the confidence of PlaqueTec's existing investors in the company's potential and highlights the ongoing interest in medtech innovations, particularly those focused on cardiovascular health.

Investor: Lord Moynihan of Chelsea, Future Fund